Skip to main content
MedPathMedPath Home
Clinical Trials/NCT01521676
NCT01521676
Terminated
Not Applicable

Research of Predictive Clinical and Biological Parameters in Breast Cancer

Institut Paoli-Calmettes4 sites in 1 country749 target enrollmentDecember 22, 2010
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsBreast Cancer
Interventionsmolecular alteration

Overview

Phase
Not Applicable
Intervention
molecular alteration
Conditions
Breast Cancer
Sponsor
Institut Paoli-Calmettes
Enrollment
749
Locations
4
Primary Endpoint
molecular alteration in breast cancer
Status
Terminated
Last Updated
11 days ago
OverviewInvestigatorsEligibility CriteriaArms & InterventionsOutcomesSitesSimilar Trials

Overview

Brief Summary

Research of predictive clinical and biological factors in breast cancer :

genomic, proteomic, mutation

Registry
clinicaltrials.gov
Start Date
December 22, 2010
End Date
January 15, 2026
Last Updated
11 days ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Institut Paoli-Calmettes
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • •breast cancer
  • •age \> 18
  • •signed informed consent

Exclusion Criteria

  • •emergency

Arms & Interventions

breast cancer

blood and tumor sample

Intervention: molecular alteration

Outcomes

Primary Outcomes

molecular alteration in breast cancer

Time Frame: average of 4 weeks after diagnosis

gene expression level

Secondary Outcomes

  • relation between molecular alteration and clinical and histological characteristics(up to 3 years)

Study Sites (4)

Loading locations...

Similar Trials

Active, not recruiting
Not Applicable
Predictive Clinical and Biological Parameters in Gynecological CancerOvarian CancerEndometrium CancerCervix Cancer
NCT01977274Institut Paoli-Calmettes300
Unknown
Not Applicable
Analysis of Prognostic and Predictive Genomic Signatures Using Archival Paraffin-embedded Breast Tumor - a Pilot StudyBreast Tumor
NCT01247467National University Hospital, Singapore10
Recruiting
Not Applicable
Transcriptional and Epimetabolic Profile of Breast Carcinoma With Luminal or HER2+ or Locally Advanced Triple-negative Histotype in Patients With/Without Previous Clinical History of Metabolic SyndromeBreast CancerMetabolic Syndrome
NCT06261918Fondazione Policlinico Universitario Agostino Gemelli IRCCS120
Withdrawn
Not Applicable
Markers for Predicting Risk of Breast Cancer in Women of Different RacesBreast Cancer
NCT02574546Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Terminated
Not Applicable
Evaluation of Specific Biomarkers in Primary Invasive Breast CancerNeoplasms, Breast
NCT01476111GlaxoSmithKline117